Zhengye Biotechnology Holding (ZYBT) Cash & Equivalents Growth (1y) (2023 - 2025)
Analysis
Zhengye Biotechnology Holding (ZYBT) Cash & Equivalents Growth (1y) (2023 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 19.65% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 2.86% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | -1.67% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | -9.73% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 47.71% |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | 174.00% |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 23.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 174.00% |
| Dec 31, 2024 | -31.41% |
| Dec 31, 2023 | 175.54% |